Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vystar Corp | 525,000 | reported | 14 Mar 2011 | tx 4+775,000−200,000 |
| GALECTIN THERAPEUTICS INC | 100,000 | reported | 16 Jan 2026 | tx 109+2,050,711−1,220,500 |
| CORAUTUS GENETICS INC | 80,000 | reported | 15 May 2006 | tx 4+141,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 100,000 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 65,000 | 0.00 USD | deriv |
| 02 Jan 2026 | EXERCISE | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | |
| 06 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 20,354 | 3.67 USD | |
| 05 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 25,732 | 3.90 USD | |
| 02 Jan 2026 | SALE | GALECTIN THERAPEUTICS INC | 13,914 | 4.20 USD | |
| 01 Jan 2026 | EXERCISE | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 9,586 | 1.98 USD | |
| 18 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 18,210 | 6.22 USD | |
| 17 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 9,586 | 6.03 USD | |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 19,701 | 1.11 USD | |
| 17 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 19,701 | 6.03 USD | |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 2,323 | 1.23 USD | |
| 17 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 2,323 | 6.03 USD | |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 28,100 | 1.98 USD | |
| 18 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 28,100 | 6.22 USD | |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 18,210 | 1.11 USD | |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 28,120 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 2,323 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 19,701 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 9,586 | 0.00 USD | deriv |
| 18 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 18,190 | 0.00 USD | deriv |
| 10 Nov 2025 | EXERCISE | GALECTIN THERAPEUTICS INC | 1,736 | 1.23 USD | |
| 10 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 1,736 | 6.03 USD | |
| 10 Nov 2025 | SALE | GALECTIN THERAPEUTICS INC | 1,880 | 6.02 USD |
3 purchases reported after at least 12 months of silence — most recent on 17 Nov 2022.